logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. IUCT Oncopole

+33531155050
Source: Site record.
https://www.iuct-oncopole.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The IUCT-Oncopole brings together the Claudius Regaud Oncopole and several departments of Toulouse University Hospital (CHU de Toulouse). It is dedicated to cancer care, research, and education.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Human-provided. Medical school
Source: Human-provided. Research institute
Source: Trial-derived.
113Total Trials
Source: Trial-derived.
35Recruiting Trials
Source: Trial-derived.
73Active Trials
Source: Trial-derived.
30Completed Trials
Source: Trial-derived.
137Unique Conditions
Source: Trial-derived.
130Unique Sponsors

Conditions

Source: Trial-derived. Multiple Myeloma (6)Source: Trial-derived. Myelodysplastic Syndromes (5)Source: Trial-derived. Acute Myeloid Leukemia (4)Source: Trial-derived. Breast Cancer (3)Source: Trial-derived. Ovarian Cancer (3)Source: Trial-derived. Prostate Cancer (3)Source: Trial-derived. Solid Tumors (3)Source: Trial-derived. Acute Lymphoblastic Leukemia (2)

Sponsors

Source: Trial-derived. Groupe Francophone des Myelodysplasies (7)Source: Trial-derived. Assistance Publique - Hôpitaux de Paris (5)Source: Trial-derived. Celgene (5)Source: Trial-derived. Hospices Civils de Lyon (5)Source: Trial-derived. Institut Bergonié (5)Source: Trial-derived. Bristol-Myers Squibb (4)Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (4)Source: Trial-derived. Incyte Corporation (4)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. CT Scan
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CALR mutation detection and variant allele frequency quantification
Source: AI-inferred. IDH1 R132 mutation testing
Source: AI-inferred. Interferon-gamma release assay (IGRA) testing
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Measurable residual disease (MRD) assessment
Source: AI-inferred. Radiographic tumour response assessment
Source: AI-inferred. Serum and urine protein electrophoresis with immunofixation
Source: AI-inferred. Tumour imaging